Company · CIK 2038033

# GenEmbryomics Ltd

| CIK | [2038033](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002038033) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Business address | Australia |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-285074 | First-time registration Withdrawn | 2025-02-20 | 2025-04-23 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-04-23 | [RW](https://www.sec.gov/Archives/edgar/data/2038033/000143774925012742/0001437749-25-012742-index.htm) Withdrawn | 333-285074 | 0001437749-25-012742 |
| 2025-03-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2038033/999999999525000837/9999999995-25-000837-index.htm) Declared effective | 333-285074 | 9999999995-25-000837 |
| 2025-03-25 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2038033/000143774925009095/0001437749-25-009095-index.htm) Amendment | 333-285074 | 0001437749-25-009095 |
| 2025-03-17 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2038033/000143774925007827/0001437749-25-007827-index.htm) Amendment | 333-285074 | 0001437749-25-007827 |
| 2025-02-20 | [F-1](https://www.sec.gov/Archives/edgar/data/2038033/000143774925004473/0001437749-25-004473-index.htm) Registration filed | 333-285074 | 0001437749-25-004473 |
| 2024-09-24 | [DRS](https://www.sec.gov/Archives/edgar/data/2038033/000143774924029885/0001437749-24-029885-index.htm) Draft made public | 377-07458 | 0001437749-24-029885 |

[All filings of this company](https://equitycapital.markets/filings?cik=2038033) · [CSV](https://equitycapital.markets/filings.csv?cik=2038033)

---
Source page: https://equitycapital.markets/company/2038033 · Data: U.S. SEC EDGAR · CC BY 4.0